Roxadustat improves diabetic myocardial injury by upregulating HIF-1α/UCP2 against oxidative stress

Abstract Background Diabetes mellitus (DM), characterized by hyperglycemia, is intricately linked with cardiovascular complications. Hyperglycemia induces oxidative stress, compromising mitochondria energy metabolism disturbances, leading to cardiomyocyte hypoxia and dysregulation of hypoxia-inducib...

Full description

Saved in:
Bibliographic Details
Main Authors: Tingting Fang, Congcong Ma, Bingyun Yang, Meiyu Zhao, Luning Sun, Ningning Zheng
Format: Article
Language:English
Published: BMC 2025-02-01
Series:Cardiovascular Diabetology
Subjects:
Online Access:https://doi.org/10.1186/s12933-025-02601-2
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823863249837228032
author Tingting Fang
Congcong Ma
Bingyun Yang
Meiyu Zhao
Luning Sun
Ningning Zheng
author_facet Tingting Fang
Congcong Ma
Bingyun Yang
Meiyu Zhao
Luning Sun
Ningning Zheng
author_sort Tingting Fang
collection DOAJ
description Abstract Background Diabetes mellitus (DM), characterized by hyperglycemia, is intricately linked with cardiovascular complications. Hyperglycemia induces oxidative stress, compromising mitochondria energy metabolism disturbances, leading to cardiomyocyte hypoxia and dysregulation of hypoxia-inducible factor-1α (HIF-1α), thereby exacerbating diabetic myocardial injury. Roxadustat (FG-4592), as an inhibitor of HIF-PHD, reduces HIF-1α degradation and regulates the transcription and function of downstream target genes. This study explores the protective effect of FG-4592 on the diabetic myocardium and further investigates the specific mechanisms responsible for this action. Methods We established diabetic myocardial injury mice and high glucose-induced rat cardiomyocyte models, administered FG-4592 pretreatment to clarify the protective effects and related mechanisms of FG-4592 on diabetic myocardial injury by detecting changes in oxidative stress, mitochondrial function, and related pathways. Results FG-4592 demonstrated cardioprotective effects in diabetic mice by regulating mitochondrial structure and function, as well as maintaining oxidative stress balance in the myocardium. It stabilized HIF-1α, activated UCP2, and enhanced the PI3K/AKT/Nrf2 pathway, reducing mitochondrial superoxide production, improving mitochondrial respiratory potential, and modulating oxidative stress markers in high glucose-induced cardiomyocytes. Conclusions FG-4592 exerts protective effects against diabetic myocardial injury by reducing oxidative stress. The mechanism is linked with the upregulation of HIF-1α and UCP2, which subsequently activate the PI3K/AKT/Nrf2 signaling pathway.
format Article
id doaj-art-1afe5c6077794f2383e0226157846a17
institution Kabale University
issn 1475-2840
language English
publishDate 2025-02-01
publisher BMC
record_format Article
series Cardiovascular Diabetology
spelling doaj-art-1afe5c6077794f2383e0226157846a172025-02-09T12:10:59ZengBMCCardiovascular Diabetology1475-28402025-02-0124111810.1186/s12933-025-02601-2Roxadustat improves diabetic myocardial injury by upregulating HIF-1α/UCP2 against oxidative stressTingting Fang0Congcong Ma1Bingyun Yang2Meiyu Zhao3Luning Sun4Ningning Zheng5Department of Pathophysiology, College of Basic Medical Science, China Medical UniversityDepartment of Pathophysiology, College of Basic Medical Science, China Medical UniversityDepartment of Pathophysiology, College of Basic Medical Science, China Medical UniversityDepartment of Pathophysiology, College of Basic Medical Science, China Medical UniversityDepartment of Pathophysiology, College of Basic Medical Science, China Medical UniversityDepartment of Pathophysiology, College of Basic Medical Science, China Medical UniversityAbstract Background Diabetes mellitus (DM), characterized by hyperglycemia, is intricately linked with cardiovascular complications. Hyperglycemia induces oxidative stress, compromising mitochondria energy metabolism disturbances, leading to cardiomyocyte hypoxia and dysregulation of hypoxia-inducible factor-1α (HIF-1α), thereby exacerbating diabetic myocardial injury. Roxadustat (FG-4592), as an inhibitor of HIF-PHD, reduces HIF-1α degradation and regulates the transcription and function of downstream target genes. This study explores the protective effect of FG-4592 on the diabetic myocardium and further investigates the specific mechanisms responsible for this action. Methods We established diabetic myocardial injury mice and high glucose-induced rat cardiomyocyte models, administered FG-4592 pretreatment to clarify the protective effects and related mechanisms of FG-4592 on diabetic myocardial injury by detecting changes in oxidative stress, mitochondrial function, and related pathways. Results FG-4592 demonstrated cardioprotective effects in diabetic mice by regulating mitochondrial structure and function, as well as maintaining oxidative stress balance in the myocardium. It stabilized HIF-1α, activated UCP2, and enhanced the PI3K/AKT/Nrf2 pathway, reducing mitochondrial superoxide production, improving mitochondrial respiratory potential, and modulating oxidative stress markers in high glucose-induced cardiomyocytes. Conclusions FG-4592 exerts protective effects against diabetic myocardial injury by reducing oxidative stress. The mechanism is linked with the upregulation of HIF-1α and UCP2, which subsequently activate the PI3K/AKT/Nrf2 signaling pathway.https://doi.org/10.1186/s12933-025-02601-2RoxadustatDiabetes mellitusDiabetic myocardial injuryUncoupling protein 2Hypoxia-inducible factor -1αOxidative stress
spellingShingle Tingting Fang
Congcong Ma
Bingyun Yang
Meiyu Zhao
Luning Sun
Ningning Zheng
Roxadustat improves diabetic myocardial injury by upregulating HIF-1α/UCP2 against oxidative stress
Cardiovascular Diabetology
Roxadustat
Diabetes mellitus
Diabetic myocardial injury
Uncoupling protein 2
Hypoxia-inducible factor -1α
Oxidative stress
title Roxadustat improves diabetic myocardial injury by upregulating HIF-1α/UCP2 against oxidative stress
title_full Roxadustat improves diabetic myocardial injury by upregulating HIF-1α/UCP2 against oxidative stress
title_fullStr Roxadustat improves diabetic myocardial injury by upregulating HIF-1α/UCP2 against oxidative stress
title_full_unstemmed Roxadustat improves diabetic myocardial injury by upregulating HIF-1α/UCP2 against oxidative stress
title_short Roxadustat improves diabetic myocardial injury by upregulating HIF-1α/UCP2 against oxidative stress
title_sort roxadustat improves diabetic myocardial injury by upregulating hif 1α ucp2 against oxidative stress
topic Roxadustat
Diabetes mellitus
Diabetic myocardial injury
Uncoupling protein 2
Hypoxia-inducible factor -1α
Oxidative stress
url https://doi.org/10.1186/s12933-025-02601-2
work_keys_str_mv AT tingtingfang roxadustatimprovesdiabeticmyocardialinjurybyupregulatinghif1aucp2againstoxidativestress
AT congcongma roxadustatimprovesdiabeticmyocardialinjurybyupregulatinghif1aucp2againstoxidativestress
AT bingyunyang roxadustatimprovesdiabeticmyocardialinjurybyupregulatinghif1aucp2againstoxidativestress
AT meiyuzhao roxadustatimprovesdiabeticmyocardialinjurybyupregulatinghif1aucp2againstoxidativestress
AT luningsun roxadustatimprovesdiabeticmyocardialinjurybyupregulatinghif1aucp2againstoxidativestress
AT ningningzheng roxadustatimprovesdiabeticmyocardialinjurybyupregulatinghif1aucp2againstoxidativestress